Get the Stockscreener App
21.98
0.63%
-0.2672
Caredx Inc stock is traded at $21.98, with a volume of 237.02K.
It is down -0.63% in the last 24 hours and up +1.33% over the past month.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
See More
Previous Close:
$22.25
Open:
$22.25
24h Volume:
237.02K
Relative Volume:
0.34
Market Cap:
$1.14B
Revenue:
$412.82M
Net Income/Loss:
$-8.19M
P/E Ratio:
-142.65
EPS:
-0.1541
Net Cash Flow:
$64.17M
1W Performance:
-3.03%
1M Performance:
+1.33%
6M Performance:
+16.98%
1Y Performance:
+13.27%
1-Day Range:
$21.94
$22.50
1-Week Range:
$21.58
$24.02
52-Week Range:
$10.96
$24.02
Caredx Inc Stock (CDNA) Company Profile
Name
Caredx Inc
Sector
Industry
Phone
415-287-2300
Address
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
21.98 | 1.15B | 412.82M | -8.19M | 64.17M | -0.1541 |
TMO
Thermo Fisher Scientific Inc
|
470.49 | 175.70B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
183.59 | 130.44B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
562.00 | 44.34B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
133.34 | 38.25B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
364.15 | 35.87B | 3.77B | 449.25M | 240.68M | 7.8556 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-26 | Downgrade | Craig Hallum | Buy → Hold |
| Aug-26-25 | Initiated | William Blair | Mkt Perform |
| Jan-15-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Underweight |
| Aug-19-24 | Upgrade | BTIG Research | Neutral → Buy |
| May-13-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-09-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Aug-15-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-11-23 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-07-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-03-23 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-03-23 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Jul-20-21 | Resumed | BTIG Research | Buy |
| Jun-03-21 | Initiated | Goldman | Buy |
| Feb-26-21 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Oct-30-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-08-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-02-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-05-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-26-20 | Initiated | BTIG Research | Buy |
| Jun-19-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-01-19 | Resumed | Craig Hallum | Buy |
| May-09-19 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-15-19 | Initiated | Jefferies | Buy |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Sep-18-18 | Reiterated | H.C. Wainwright | Neutral |
| Nov-27-17 | Initiated | H.C. Wainwright | Buy |
| Jun-14-16 | Reiterated | Mizuho | Buy |
| Sep-29-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-25-15 | Initiated | Craig Hallum | Buy |
| Mar-18-15 | Reiterated | Mizuho | Buy |
View All
Caredx Inc Stock (CDNA) Latest News
CareDx Showcases Strong Q1 Growth and Expanding Pipeline at Jefferies - HarianBasis.co
CareDx (CDNA) Q3 2023 Earnings Call Transcript - MLQ.ai
CareDx Highlights 39% Q1 Growth, Naveris Oncology Push at Jefferies - Yahoo Finance
M3 to Acquire WISEMAN to Boost Healthcare and Nursing Care DX - TipRanks
Insider sale reported for CDNA (NASDAQ: CDNA) under 10b5-1 plan - Stock Titan
CDNA: Q1 revenue up 39%, Naveris acquisition boosts oncology, and pipeline advances in transplant and cancer - TradingView
CareDx Deadline Alert - TMX Newsfile
U.S. Supreme Court rejects CareDx appeal in Natera false-advertising dispute - Reuters
CareDx (CDNA) Supreme Court Appeal Denied, Lower Court Ruling St - GuruFocus
Justices Skip CareDx's Bid To Revive $45M False Ad Award - Law360
CAREDX INC (NASDAQ:CDNA) Shows Perfect Minervini Trend Template and High Growth Momentum Setup - ChartMill
The Technical Signals Behind (CDNA) That Institutions Follow - Stock Traders Daily
Analysts Offer Insights on Healthcare Companies: Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF) and CareDx (CDNA) - The Globe and Mail
William Blair Maintains CareDx(CDNA.US) With Hold Rating - Moomoo
28% Of This CareDx Insider's Holdings Were Sold - Moomoo
CDNA Technical Analysis & Stock Price Forecast - Intellectia AI
CareDx Earnings Call: Growth, Navaris Deal and Pivot - The Globe and Mail
CareDx to Participate in Upcoming June 2026 Investor Conferences - BioSpace
CareDx plans June talks at Jefferies and Goldman Sachs healthcare events - Stock Titan
CareDx to Participate in Upcoming Investor Conferences - The Joplin Globe
Precision Trading with Caredx Inc. (CDNA) Risk Zones - Stock Traders Daily
Insider Sell Alert: Arthur Torres Sells Shares of CareDx Inc (CD - GuruFocus
CareDx director Arthur Torres sells $214,675 in company stock By Investing.com - Investing.com Nigeria
CareDx director Arthur Torres sells $214,675 in company stock - Investing.com
CareDx (CDNA) director sells 10,570 shares in open-market trades - Stock Titan
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE's CareDx Inc(CDNA) Holding History - GuruFocus
ETFs Investing in CareDx, Inc. Stocks - TradingView
Rule 144 notice and recent sale by insider (CDNA) - Stock Titan
[144] CareDx, Inc. SEC Filing - Stock Titan
CareDx expands HeartCare platform to transform post transplant care for heart recipients - Traders Union
How Investors Are Reacting To CareDx (CDNA) Profit Return, Higher 2026 Outlook And New Shelf Registration - Sahm
CareDx (CDNA) Successfully Resolves Legal Action - GuruFocus
Caredx announces dismissal of 2021 qui tam suit - marketscreener.com
CareDx(CDNA) Stock Options Chain | Quotes & News - Moomoo
CareDx Announces Dismissal of 2021 Qui Tam Suit - marketscreener.com
Earnings Preview: CareDx to Report Financial Results Post-market on April 28 - Moomoo
The real story behind CareDx (CDNA) earnings numbers | Q1 2026: Better Than ExpectedQuarterly Profit Report - The Legal Advocate
Technical Reactions to CDNA Trends in Macro Strategies - Stock Traders Daily
Insider Sell: Jeffrey Novack Sells 2,688 Shares of CareDx Inc (C - GuruFocus
CareDx (NASDAQ: CDNA) counsel's 2,688-share sale under 10b5-1 - Stock Titan
CareDx (CDNA) Q1 2026 Earnings Call Transcript - AOL.com
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The National Law Review
A Look At CareDx (CDNA) Valuation After Recent Share Price Momentum Cools - Yahoo Finance
CareDx (CDNA) General Counsel has 2,873 shares withheld to cover RSU taxes - Stock Titan
How Investors Are Reacting To CareDx (CDNA) Profitability Milestone And Higher 2026 Revenue Guidance - Sahm
CareDx (NASDAQ:CDNA) Upgraded to Strong-Buy at Wall Street Zen - MarketBeat
MSN Money - MSN
23 new CareDx hires receive 63,856 stock units under Nasdaq rule - Stock Titan
CareDx sharpens focus on core testing services - MSN
Caredx Inc Stock (CDNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Caredx Inc Stock (CDNA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| TORRES ARTHUR A | Director |
May 15 '26 |
Sale |
19.89 |
6,484 |
128,978 |
38,665 |
| TORRES ARTHUR A | Director |
May 14 '26 |
Sale |
20.97 |
4,086 |
85,698 |
45,149 |
1.59%
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):